Mexico prepares clinical trial of CAR-T cells to treat leukemia in adults after approval from Cofepris
World1 source1 country🔦 Under-reported24m ago
Mexico's health regulatory agency, the Federal Commission for the Protection against Sanitary Risks (Cofepris), has authorized the country's first clinical trial utilizing CAR-T cell therapy to treat leukemia in adults.
The experimental treatment involves modifying T-lymphocytes, a type of white blood cell extracted from a patient's blood, to better target the disease. The authorized CAR-T cells for this clinical trial are specifically manufactured within Mexico by the Autonomous University of Nuevo León, located in the northern region of the country.
This authorization marks a significant milestone for advanced medical research and biotechnology in Mexico, enabling domestic production and clinical evaluation of this specialized immunotherapy for adult leukemia patients.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
Infobae (Buenos Aires, Argentina) (AR) - First snippetFocuses on adult leukemia treatment and the definition of CAR-T cells.
Infobae (Buenos Aires, Argentina) (AR) - Second snippetEmphasizes domestic manufacturing of the therapy by the Autonomous University of Nuevo León.
Newz